Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 548
5
Diseases
10
Unique genes
0.266
Avg. similarity score
Headache
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Headache
Angiofollicular ganglionic hyperplasia
Angiolymphoid hyperplasia
Castleman disease
Congenital microtia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Headache | 4 | 4 | 10 |
| Angiofollicular ganglionic hyperplasia | 3 | 3 | 1 |
| Angiolymphoid hyperplasia | 3 | 3 | 1 |
| Castleman disease | 3 | 3 | 1 |
| Congenital microtia | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| IL6 | 4 / 5 | Angiofollicular ganglionic hyperplasia, Angiolymphoid hyperplasia, Castleman disease, Headache |
| PRKRA | 2 / 5 | Congenital microtia, Headache |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| JAK-STAT signaling pathway | KEGG | 3 / 168 | 21.4× | 3.00e-4 | 4.51e-3 ✓ sig. |
| Interleukin-10 signaling | Reactome | 2 / 47 | 51.1× | 6.61e-4 | 8.28e-3 ✓ sig. |
| Malaria | KEGG | 2 / 50 | 48.0× | 7.48e-4 | 9.09e-3 ✓ sig. |
| Coronavirus disease - COVID-19 | KEGG | 3 / 238 | 15.1× | 8.32e-4 | 9.85e-3 ✓ sig. |
| Vitamin E | Reactome | 1 / 1 | 1,201× | 8.33e-4 | 9.85e-3 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 3 / 298 | 12.1× | 1.59e-3 | 1.61e-2 ✓ sig. |
| Cytosolic DNA-sensing pathway | KEGG | 2 / 83 | 28.9× | 2.05e-3 | 1.93e-2 ✓ sig. |
| IL-17 signaling pathway | KEGG | 2 / 94 | 25.6× | 2.62e-3 | 2.32e-2 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 3 / 361 | 10.0× | 2.76e-3 | 2.40e-2 ✓ sig. |
| Hematopoietic cell lineage | KEGG | 2 / 100 | 24.0× | 2.96e-3 | 2.52e-2 ✓ sig. |
| Toll-like receptor signaling pathway | KEGG | 2 / 109 | 22.0× | 3.50e-3 | 2.83e-2 ✓ sig. |
| Vasopressin-like receptors | Reactome | 1 / 6 | 200× | 4.99e-3 | 3.64e-2 ✓ sig. |
| Measles | KEGG | 2 / 139 | 17.3× | 5.63e-3 | 3.95e-2 ✓ sig. |
| Alcoholic liver disease | KEGG | 2 / 144 | 16.7× | 6.03e-3 | 4.12e-2 ✓ sig. |
| CD163 mediating an anti-inflammatory response | Reactome | 1 / 9 | 133× | 7.47e-3 | 4.73e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to prostaglandin E | GO:0034695 | 2 / 11 | 340× | 1.41e-5 | 7.12e-4 ✓ sig. |
| positive regulation of ossification | GO:0045778 | 2 / 21 | 178× | 5.38e-5 | 1.95e-3 ✓ sig. |
| cell surface receptor signaling pathway via STAT | GO:0097696 | 2 / 28 | 133× | 9.67e-5 | 3.01e-3 ✓ sig. |
| response to steroid hormone | GO:0048545 | 2 / 30 | 125× | 1.11e-4 | 3.34e-3 ✓ sig. |
| response to peptide hormone | GO:0043434 | 2 / 50 | 74.7× | 3.11e-4 | 6.97e-3 ✓ sig. |
| response to activity | GO:0014823 | 2 / 52 | 71.9× | 3.37e-4 | 7.28e-3 ✓ sig. |
| response to glucocorticoid | GO:0051384 | 2 / 53 | 70.5× | 3.50e-4 | 7.49e-3 ✓ sig. |
| humoral immune response | GO:0006959 | 2 / 58 | 64.4× | 4.19e-4 | 8.47e-3 ✓ sig. |
| regulation of astrocyte activation | GO:0061888 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| glucagon secretion | GO:0070091 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| positive regulation of hindgut contraction | GO:0060450 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| negative regulation of establishment of blood-brain barrier | GO:0090212 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| negative regulation of immature T cell proliferation | GO:0033087 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| external genitalia morphogenesis | GO:0035261 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| female pregnancy | GO:0007565 | 2 / 80 | 46.7× | 7.97e-4 | 1.28e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Angiofollicular ganglionic hyperplasia | Angiolymphoid hyperplasia | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Angiofollicular ganglionic hyperplasia | Castleman disease | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Angiolymphoid hyperplasia | Castleman disease | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Congenital microtia | Headache | 0.091 | 1 | 6.46e-4 | 1.09e-3 ✓ sig. |
| Angiofollicular ganglionic hyperplasia | Headache | 0.091 | 1 | 6.46e-4 | 1.09e-3 ✓ sig. |
| Angiolymphoid hyperplasia | Headache | 0.091 | 1 | 6.46e-4 | 1.09e-3 ✓ sig. |
| Castleman disease | Headache | 0.091 | 1 | 6.46e-4 | 1.09e-3 ✓ sig. |